E-LIB Suche - Ergebnisse für: Pournara, Effie

1

Magnetic resonance imaging characteristics in patients with..:

Baraliakos, Xenofon ; Pournara, Effie ; Coates, Laura C...
Rheumatology. 63 (2023) 1 - p. 85-92 , 2023

Link: https://doi.org/10.1093/..

2

Immune response to severe acute respiratory syndrome corona..:

Gisondi, Paolo ; Simon, David ; Alarcon, Ivette..
Journal of Dermatological Treatment. 34 (2023) 1 - p. , 2023

Link: https://doi.org/10.1080/..

3

Inhibition of Interleukin-17 in Patients with Oligoarticula..:

Ogdie, Alexis ; Gladman, Dafna D. ; Coates, Laura C....
Rheumatology and Therapy. 10 (2023) 4 - p. 849-860 , 2023

Link: https://doi.org/10.1007/..

4

Comment on: MRI characteristics in patients with psoriatic ..:

Baraliakos, Xenofon ; Pournara, Effie ; Coates, Laura C...
Rheumatology. , 2023

Link: https://doi.org/10.1093/..

5

P254 Secukinumab retention and safety in patients with acti..:

Gaffney, Karl ; Kiltz, Uta ; Sfikakis, Petros...
Rheumatology. 61 (2022) Supplement_1 - p. , 2022

Link: https://doi.org/10.1093/..

6

34346 Pooled safety analysis of respiratory tract infection..:

Schulze-Koops, Hendrik ; Deodhar, Atul ; Voll, Reinhard E....
Journal of the American Academy of Dermatology. 87 (2022) 3 - p. AB192 , 2022

Link: https://doi.org/10.1016/..

7

OA35 Efficacy of secukinumab and HLA-B27 subtypes: results ..:

Marzo-Ortega, Helena ; Poddubnyy, Denis ; Pournara, Effie...
Rheumatology. 61 (2022) Supplement_1 - p. , 2022

Link: https://doi.org/10.1093/..

8

P260 Secukinumab in Patients With Psoriatic Arthritis and A..:

Coates, Laura C ; Baraliakos, Xenofon ; Pournara, Effie...
Rheumatology. 61 (2022) Supplement_1 - p. , 2022

Link: https://doi.org/10.1093/..

9

Secukinumab demonstrates high and sustained efficacy in nai..:

Reich, Kristian ; Baraliakos, Xenophon ; Coates, Laura C....
British Journal of Dermatology. , 2022

Link: https://doi.org/10.1111/..

10

Predictors of response to secukinumab in patients with psor..:

Baraliakos, Xenofon ; Pournara, Effie ; Gossec, Laure...
RMD Open. 8 (2022) 2 - p. e002303 , 2022

Link: https://doi.org/10.1136/..

11

P268 Impact of intermediate treatment interruption on secuk..:

Gaffney, Karl ; Kiltz, Uta ; Sfikakis, Petros...
Rheumatology. 61 (2022) Supplement_1 - p. , 2022

Link: https://doi.org/10.1093/..

12

Interim 2-Year Analysis from SERENA: A Real-World Study in ..:

Kiltz, Uta ; Sfikakis, Petros P. ; Gaffney, Karl...
Rheumatology and Therapy. 9 (2022) 4 - p. 1129-1142 , 2022

Link: https://doi.org/10.1007/..

13

P266 Secukinumab provides clinical improvements in patients..:

Coates, Laura C ; Ogdie, Alexis ; Gladman, Dafna D...
Rheumatology. 61 (2022) Supplement_1 - p. , 2022

Link: https://doi.org/10.1093/..

14

Effectiveness and Safety of Secukinumab for Psoriasis in a ..:

Foley, Peter ; Tsai, Tsen-Fang ; Rodins, Karl...
Dermatology and Therapy. 12 (2022) 2 - p. 511-527 , 2022

Link: https://doi.org/10.1007/..

15

Rapid improvement in spinal pain in patients with axial spo..:

Poddubnyy, Denis ; Pournara, Effie ; Zielińska, Agnieszka...
Therapeutic Advances in Musculoskeletal Disease. 13 (2021) - p. 1759720X2110514 , 2021

Link: https://doi.org/10.1177/..